Corporate Compliance Programs Now Accountable To “Two Agencies” – Pitt
This article was originally published in The Gray Sheet
Executive Summary
Device firms may need to become more proactive on Securities & Exchange Commission compliance issues under the agency's formal alliance with FDA on regulating investor communications
You may also be interested in...
FDA Centralizes Internal Procedure For SEC Communications
FDA's new process for referring information to the Securities & Exchange Commission could result in heightened CDRH attention to potentially false or misleading statements by device firms
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.